1998
DOI: 10.1213/00000539-199804000-00011
|View full text |Cite
|
Sign up to set email alerts
|

A Comparison of the Efficacy, Safety, and Patient Satisfaction of Ondansetron Versus Droperidol as Antiemetics for Elective Outpatient Surgical Procedures

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
52
0
1

Year Published

2000
2000
2020
2020

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 146 publications
(57 citation statements)
references
References 25 publications
3
52
0
1
Order By: Relevance
“…In this study, the incidence of PONV was 17% after using 2.5 mg droperidol. It has been reported that the incidences of PONV were 37% after using 0.625 mg droperidol and 31% after using 1.25 mg droperidol [6]. With increasing doses, droperidol's anti-vomiting effi cacy improved considerably, although doses beyond 2.5 mg did not further increase effi cacy [7].…”
Section: Discussionmentioning
confidence: 99%
“…In this study, the incidence of PONV was 17% after using 2.5 mg droperidol. It has been reported that the incidences of PONV were 37% after using 0.625 mg droperidol and 31% after using 1.25 mg droperidol [6]. With increasing doses, droperidol's anti-vomiting effi cacy improved considerably, although doses beyond 2.5 mg did not further increase effi cacy [7].…”
Section: Discussionmentioning
confidence: 99%
“…We analyzed data collected in a previously published large multicenter study [2] to assess the effectiveness of different antiemetics for the treatment of established PONV in patients who failed prophylaxis.…”
Section: Methodsmentioning
confidence: 99%
“…Moreover, it is unclear if an antiemetic acting on a different receptor system would constitute a better treatment option in patients who experience PONV despite receiving a prophylactic antiemetic. We reexamined the database of a previously published large multicenter study to determine the efficacy of rescue antiemetics in patients who failed prophylaxis with ondansetron 4 mg and droperidol 0.625 to 1.25 mg [2]. We hypothesized that in patients who fail prophylaxis with one antiemetic, a rescue agent working at a different receptor would have a higher success rate compared with a repeat dose of the same antiemetic used for prophylaxis.…”
Section: Introductionmentioning
confidence: 99%
“…Although ondansetron (an antagonist of the 5-HT3 receptor), is as effective as older antiemetics such as droperidol [97] or cyclizine [98], it avoids most of their adverse effects. Ondansetron given at the end of surgery results in a significantly greater antiemetic effect, compared with preinduction dosing [99].…”
Section: Antiemetic Medicationsmentioning
confidence: 99%